These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32942096)

  • 1. Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors.
    Zhang KX; Ip CK; Chung SK; Lei KK; Zhang YQ; Liu L; Wong VKW
    Curr Opin Pharmacol; 2020 Oct; 54():59-71. PubMed ID: 32942096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
    van der Heijden JW; Oerlemans R; Tak PP; Assaraf YG; Kraan MC; Scheffer GL; van der Laken CJ; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Arthritis Rheum; 2009 Mar; 60(3):669-77. PubMed ID: 19248091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis.
    Gao J; Wang C; Wei W
    Life Sci; 2021 Mar; 268():118907. PubMed ID: 33428880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
    Finckh A; Dehler S; Gabay C;
    Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR-ABC transporters: biomarkers in rheumatoid arthritis.
    Márki-Zay J; Tauberné Jakab K; Szerémy P; Krajcsi P
    Clin Exp Rheumatol; 2013; 31(5):779-87. PubMed ID: 23711386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic agents in rheumatoid arthritis: an update for managed care professionals.
    Agarwal SK
    J Manag Care Pharm; 2011; 17(9 Suppl B):S14-8. PubMed ID: 22073935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
    Stamp LK; Hazlett J; Highton J; Hessian PA
    J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy.
    Inoue K; Yuasa H
    Drug Metab Pharmacokinet; 2014; 29(1):12-9. PubMed ID: 24284432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
    Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis.
    Iannone F; Lopalco G; Cantarini L; Galeazzi M; Lapadula G
    Clin Rheumatol; 2016 Jan; 35(1):19-23. PubMed ID: 26581205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
    Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
    Kerschbaumer A; Sepriano A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JWJ; Burmester GR; de Wit M; Falzon L; Landewé R
    Ann Rheum Dis; 2020 Jun; 79(6):744-759. PubMed ID: 32033937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.
    van der Heijden JW; Dijkmans BA; Scheper RJ; Jansen G
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):26-34. PubMed ID: 17203006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.
    Woodworth TG; den Broeder AA
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):543-9. PubMed ID: 26697765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis.
    Zhang LL; Yang S; Wei W; Zhang XJ
    Pharmacogenet Genomics; 2014 Nov; 24(11):531-8. PubMed ID: 25144752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TNF- alpha gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-alpha agents: preliminary results].
    Fabris M; Di Poi E; Sacco S; Damante G; Sinigaglia L; Ferraccioli G
    Reumatismo; 2002; 54(1):19-26. PubMed ID: 12089610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.